Latest content
- Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate
- VML Health appoints Jason Graff as Global CCO
- J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis
- Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development
- Pfizer and Innovent Biologics agree on deal worth up to $10.5bn